Table 1.
Baseline clinical characteristics of enrolled subjects
| Group | NC | RVR | EVR | NR |
|---|---|---|---|---|
| Case | 24 | 44 | 51 | 19 |
| Sex (male/female) | 15/9 | 20/24 | 28/23 | 12/7 |
| Age (years) | 29 (23–36) | 31 (18–46) | 31 (19–65) | 28 (20–42) |
| ALT (U/l) | 25 (12–40) | 43 (9–142) | 56 (32–198) | 40 (21–173) |
| HCV RNA (log10 copies/ml) | N.D. | 4·32 (2·15–7·24) | 5·42 (2·72–6·21) | 4·82 (3·52–5·98) |
| HCV genotype (1b/2a) | N.D. | 30/14 | 33/18 | 16/3 |
Data are shown as median and range. NC, normal control; RVR, rapid virological response; EVR, early virological response; NR, Non-response; ND, not determined.